There are many available types. The following are for your information only and should be checked for the latest available data. Here they are but know that the doctor may prescribe a mixture of types:
- The rapid acting ones are absorbed faster than the short-acting ones but wears off earlier like Insulin aspart, insulin glulisine, insulin lispro. They start working either after 15 minutes, with peak times of 30 minutes to three hours and effect lasts from two to five hours.
- The short-acting ones work faster but the effects do not last as long as the intermediate ones like Humulin R, Novolin R. It begins to work 30 to 60 minutes with peak times of 2 to four hours and effect lasts for 3 to 8 hours.
- The intermediate-acting ones begin working later than the short-acting ones but the effects last longer like the NPH human (Humulin N, Novolin N). It starts working later than the short-acting ones. It starts working one to four hours, with peak times at 4 to 12 hours and the effect lasts for 12 to 18 hours.
- The long-acting ones take several hours to work but it supplies the insulin at a steady level for one whole day or 24 hours like Insulin glargine (Lantus) and the Insulin detemir (Levemir). It starts working in one to ten hours, with no clear peak and the effect lasts for up to 24 hours.
Remember that depending on when you read this, the data may have changed and that the doctor has the final say on this as he will know the overall health condition of the person in question. You can read more about insulin at this site where you can sign up for free to get alert and tips delivered right to your email inbox. While there you can also access the home page for the disclaimer.
Bovine insulin and Hypurin porcine will still be supplied for diabetics as soon as Novo Nordisk extracts its pork insulin. This is why Wockhardt UK says they’ll be able to provide the diabetics this option for treatment.
Diabetes UK Care advisor Cathy Moulton says it is good for the diabetics to have a choice of treatment because no two diabetics are alike so they want to still provide animal insulin. The other point is that switching to human insulin from the animal type is not simple because of serious reaction to the change.
Diabetes UK had a report specially made for this issue that was published in the magazine Diabetic Medicine. Although many can deal with their diabetes well with human insulin, few have problems with hypoglycemia when treated with it. So the Department of Health agrees that some diabetics are more suited to bovine insulin and should therefore be made available.